dacarbazine and Adenoma

dacarbazine has been researched along with Adenoma in 58 studies

Research

Studies (58)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (8.62)	29.6817
2010's	51 (87.93)	24.3611
2020's	2 (3.45)	2.80

Authors

Authors	Studies
Barbot, M; Bergo, E; Caccese, M; Ceccato, F; Cerretti, G; Lombardi, G; Occhi, G; Padovan, M; Scaroni, C	1
Geer, EB	1
Lenders, N; McCormack, A	1
Gilis-Januszewska, A; Hubalewska-Dydejczyk, A; Kluczyński, Ł; Pach, D; Pantofliński, J; Sokołowski, G; Sowa-Staszczak, A; Turek-Jabrocka, R; Wilusz, M; Zieliński, G	1
Burman, P; Dekkers, OM; McCormack, A; Petersenn, S; Popovic, V; Raverot, G; Trouillas, J	1
Even-Zohar, N; Greenman, Y	1
Hirohata, T; Hoya, K; Ide, F; Ishii, Y; Matsuno, A; Miyamoto, S; Mizutani, A; Murakami, M; Nagashima, H; Nishido, H; Okinaga, H; Osamura, RY; Son, JH; Sugaya, M; Tahara, S; Teramoto, A; Yamada, S; Yamada, SM	1
Bruce, JN; Carminucci, AS; Fine, RL; Gulati, AP; Lignelli, A; Remotti, H; Siegelin, M; Wardlaw, SL; Zacharia, BE	1
Jouanneau, E; Raverot, G; Trouillas, J	1
Cusimano, MD; Di Ieva, A; Kovacs, K; Rotondo, F; Syro, LV	1
Ambrosi, B; Corbetta, S; Mendola, M; Passeri, E	1
Hu, Y; Li, J; Li, W; Lu, Z; Ma, C; Tohti, M; Wang, S; Wang, Y	1
Cantelli, E; De Vries, S; Dekker, M; Delzenne-Goette, E; Plug, M; Song, JY; Te Riele, H; Van Der Wal, A; Van Gerwen, B; Wojciechowicz, K	1
Hirohata, T; Ishii, Y; Matsuno, A	1
Jiang, S; Yin, S; Zhong, C; Zhou, P	1
Bertorelle, R; Boscaro, M; Ceccato, F; D'Avella, D; Denaro, L; Emanuelli, E; Gardiman, MP; Lombardi, G; Manara, R; Milanese, L; Occhi, G; Scanarini, M; Scaroni, C; Zagonel, V	1
Bruno, OD; Christiansen, SB; Danilowicz, K; Juárez-Allen, L	1
Laterra, JJ; Salvatori, R; Strowd, RE	1
Andersen, M; Bengtsson, D; Berinder, K; Burman, P; Feldt Rasmussen, U; Hoybye, C; Johannsson, G; Maiter, D; Petersson, M; Ragnarsson, O; Rasmussen, ÅK; Schrøder, HD; van der Lely, AJ	1
Amirbaigloo, A; Cusimano, MD; Di Ieva, A; Fathalla, H; Ghazi, AA; Kovacs, K; Rotondo, F; Syro, LV	1
Eloy, JA; Liu, JK; Patel, J	1
Chen, W; Fan, B; Li, T; Xiao, Z; Yang, J; Zhao, Y	1
Curtò, L; Trimarchi, F	1
Aller, J; Campderá, M; Estrada, J; Lilienfeld, H; Magallón, R; Martín, P; Palacios, N; Saucedo, G	1
Bogazzi, F; Cannavo, S; Ceccato, F; Curtò, L; De Marinis, L; Iacovazzo, D; Lombardi, G; Losa, M; Mantovani, G; Mazza, E; Minniti, G; Nizzoli, M; Reni, M; Scaroni, C	1
Bin, X; Bingbing, X; Dongchun, W; Kun, Z; Xiaoli, L; Yuling, Y	1
Brown, PD; Cachia, D; Crane, CH; Kamiya-Matsuoka, C; Mahajan, A; McCutcheon, IE; Nam, JY; Penas-Prado, M; Waguespack, SG	1
DeAngelis, LM; Lin, AL; Sum, MW	1
Arnal, AV; Donovan, LE; Odia, Y; Wang, SH	1
Abbritti, RV; Angileri, FF; Baldari, S; Barresi, V; Cannavò, S; Conti, A; Esposito, F; Ferraù, F; Germanò, A; Priola, SM; Tomasello, F	1
Denew, P; Kurowska, M; Maksymowicz, M; Malicka, J; Tarach, JS; Zieliński, G	1
Bao, X; Dai, C; Deng, K; Feng, M; Lian, W; Liu, X; Ma, S; Ma, W; Sun, B; Wang, R; Wang, Y; Xing, B; Yao, Y; Zhong, D	1
Czech, T; Knosp, E; Kotter, MR; Marosi, C; Preusser, M; Widhalm, G; Woehrer, A; Wolfsberger, S	1
Cusimano, MD; Kovacs, K; Mason, W; Mohammed, S; Smyth, H	1
Matsuno, A	1
Bruce, JN; Fine, RL; Freda, PU; Isaacson, SR; Lee, Y; Thearle, MS	1
Alameda Hernando, C; Lahera Vargas, M; Varela Da Costa, C	1
Erickson, D; Fealey, ME; Horvath, E; Kovacs, K; Lloyd, RV; McLendon, R; Scheithauer, BW	1
Del Porto, L; Dobson, M; Maartens, NF	1
Albayrak, M; Coskun, U; Gursel, T; Kaya, Z; Keskin, EY; Kocak, U; Uluoglu, O	1
Cusimano, M; Gonzalez, R; Horvath, E; Kovacs, K; Lau, Q; Lloyd, R; Ortiz, LD; Scheithauer, BW; Syro, LV; Uribe, H	1
Cangi, MG; Gill, AJ; Losa, M; Mazza, E; McCormack, A; Mortini, P; Motta, M; Reni, M; Talarico, A; Terreni, MR	1
Altavilla, G; Cannavò, S; Curtò, L; Ferraù, F; Granata, F; Hofland, LJ; Longo, M; Pitini, V; Torre, ML; Trimarchi, F	1
Drake, WM; Horvath, E; Kovacs, K; Manoranjan, B; Moyes, VJ; Salehi, F; Scheithauer, BW; Sharma, S; Syro, LV	1
Erickson, D; Fealey, M; Horvath, E; Kovacs, K; Kros, JM; Lau, Q; Lloyd, RV; Salehi, F; Scheithauer, BW	1
Marucci, G	1
Grossman, AB; McCormack, AI; Wass, JA	1
Hueng, DY; Liu, MY; Ma, HI; Sytwu, HK	1
Bao, X; Cai, F; Dai, C; Feng, M; Li, G; Liu, X; Ma, S; Ma, W; Wang, R; Wei, J; Yao, Y; Zhang, B	1
Altuntaş, Y; Çil, E; Karaman, Ö; Müslüman, AM; Özkayalar, H; Öztürk, FY; Tanik, C; Velet, S; Zuhur, SS	1
Ersen, A; Fadul, CE; Horvath, E; Kovacs, K; Ortiz, LD; Rotondo, F; Scheithauer, BW; Syro, LV; Uribe, H	1
Annamalai, AK; Antoun, NM; Burnet, NG; Burton, H; Cheow, HK; Dean, AF; Gurnell, M; Halsall, DJ; Jefferies, SJ; Kandasamy, N; Kirollos, RW; Kovacs, K; Pickard, JD; Shaw, AS; Simpson, HL	1
Fadul, CE; Horvath, E; Kovacs, K; Ortiz, LD; Rotondo, F; Scheithauer, BW; Syro, LV; Uribe, H	1
Ersen, A; Horvath, E; Kovacs, K; Ortiz, LD; Penagos, L; Rotondo, F; Scheithauer, BW; Syro, LV; Uribe, H	1
Amano, K; Arita, K; Asano, K; Fujio, S; Fukuhara, N; Hirohata, T; Hizuka, N; Ikeda, H; Ishii, Y; Isozaki, O; Iwai, Y; Kawamata, T; Matsuno, A; Nishioka, H; Ogawa, Y; Osamura, RY; Sakata, K; Shimatsu, A; Tahara, S; Takano, K; Takano, S; Teramoto, A; Tominaga, A; Yamada, S	1
Bao, X; Cai, F; Dai, C; Feng, M; Guo, K; Li, G; Lian, W; Liu, X; Ma, S; Ma, W; Wang, J; Wang, R; Xiao, J; Xing, B; Yang, Y; Yao, Y; Zhang, B; Zhang, H	1
Isayama, Y; Kawashima, K; Takashima, H	1
Sakumi, K; Sekiguchi, M; Shiraishi, A	1

Reviews

18 review(s) available for dacarbazine and Adenoma

Article	Year
Knowing when to discontinue Temozolomide therapy in responding aggressive pituitary tumors and carcinomas: a systematic review and Padua (Italy) case series. Expert review of endocrinology & metabolism, 2023, Volume: 18, Issue:2 Topics: Adenoma; Antineoplastic Agents, Alkylating; Carcinoma; Dacarbazine; Humans; Pituitary Neoplasms; Temozolomide	2023
Medical therapy for refractory pituitary adenomas. Pituitary, 2023, Volume: 26, Issue:3 Topics: Adenoma; Antineoplastic Agents, Alkylating; Dacarbazine; Humans; Pituitary Neoplasms; Temozolomide	2023
Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma). Pituitary, 2018, Volume: 21, Issue:2 Topics: Adenoma; Animals; Cell Transformation, Neoplastic; Dacarbazine; Humans; Pituitary Neoplasms; Temozolomide	2018
Temozolomide therapy for aggressive pituitary Crooke's cell corticotropinoma causing Cushing's Disease - a case report with literature review. Endokrynologia Polska, 2018, Volume: 69, Issue:3 Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Antineoplastic Agents, Alkylating; Dacarbazine; Fatal Outcome; Humans; Male; Middle Aged; Pituitary ACTH Hypersecretion; Temozolomide	2018
Management of NFAs: medical treatment. Pituitary, 2018, Volume: 21, Issue:2 Topics: Adenoma; Dacarbazine; Dopamine Agonists; Female; Humans; Male; Pituitary Neoplasms; Temozolomide	2018
Molecular status of pituitary carcinoma and atypical adenoma that contributes the effectiveness of temozolomide. Medical molecular morphology, 2014, Volume: 47, Issue:1 Topics: Adenoma; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Dacarbazine; DNA-Binding Proteins; Humans; O(6)-Methylguanine-DNA Methyltransferase; Pituitary Neoplasms; Temozolomide; Treatment Outcome	2014
Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies. European journal of endocrinology, 2014, Volume: 170, Issue:4 Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adrenocorticotropic Hormone; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Dacarbazine; Follicle Stimulating Hormone; Growth Hormone-Secreting Pituitary Adenoma; Human Growth Hormone; Humans; Luteinizing Hormone; Pituitary Hormones, Anterior; Pituitary Neoplasms; Prognosis; Prolactin; Prolactinoma; Temozolomide; Thyrotropin	2014
Aggressive pituitary adenomas--diagnosis and emerging treatments. Nature reviews. Endocrinology, 2014, Volume: 10, Issue:7 Topics: Adenoma; Biomarkers, Tumor; Dacarbazine; Humans; Ki-67 Antigen; Neoplasm Invasiveness; Neovascularization, Pathologic; Pituitary Neoplasms; Temozolomide; Tumor Suppressor Protein p53	2014
Treatment of pituitary carcinomas and atypical pituitary adenomas: a review. Neurologia medico-chirurgica, 2014, Volume: 54, Issue:12 Topics: Adenoma; Administration, Oral; Antineoplastic Agents, Alkylating; Cell Transformation, Neoplastic; Combined Modality Therapy; Dacarbazine; Disease Progression; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Pituitary Gland; Pituitary Hormones; Pituitary Neoplasms; Temozolomide	2014
Treatment of invasive silent somatotroph pituitary adenoma with temozolomide. Report of a case and review of the literature. Endocrine pathology, 2015, Volume: 26, Issue:2 Topics: Adenoma; Adult; Antineoplastic Agents, Alkylating; Asymptomatic Diseases; Dacarbazine; Growth Hormone-Secreting Pituitary Adenoma; Humans; Male; Neoplasm Invasiveness; Temozolomide	2015
The role of temozolomide in the treatment of aggressive pituitary tumors. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2015, Volume: 22, Issue:6 Topics: Adenoma; Animals; Antineoplastic Agents, Alkylating; Apoptosis; Dacarbazine; Disease Progression; DNA Damage; DNA Modification Methylases; DNA Repair Enzymes; Humans; Mutation; Neoplasm Recurrence, Local; Pituitary Neoplasms; Temozolomide; Tumor Suppressor Proteins	2015
Is there a role for early chemotherapy in the management of pituitary adenomas? Neuro-oncology, 2016, Volume: 18, Issue:10 Topics: Adenoma; Antineoplastic Agents; Dacarbazine; Humans; Pituitary Neoplasms; Temozolomide	2016
[Recent trends in the pathophysiology and treatment of pituitary adenomas]. Brain and nerve = Shinkei kenkyu no shinpo, 2009, Volume: 61, Issue:8 Topics: Adenoma; Antineoplastic Agents; Cabergoline; Corticotropin-Releasing Hormone; Dacarbazine; Ergolines; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypothalamic Hormones; Incidental Findings; Neurosurgical Procedures; Octreotide; Pituitary Neoplasms; Prolactinoma; Receptors, Neuropeptide; Receptors, Pituitary Hormone-Regulating Hormone; Temozolomide	2009
[Treatment of clinically nonfunctioning pituitary adenomas]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2010, Volume: 57, Issue:2 Topics: Adenoma; Adult; Cranial Irradiation; Dacarbazine; Decompression, Surgical; Dopamine Agonists; Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Hypophysectomy; Male; Neoplasm, Residual; Pituitary Neoplasms; Postoperative Complications; Radiosurgery; Radiotherapy, Intensity-Modulated; Somatostatin; Temozolomide	2010
Treatment of pituitary neoplasms with temozolomide: a review. Cancer, 2011, Feb-01, Volume: 117, Issue:3 Topics: Adenoma; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Carcinoma; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Humans; Pituitary Neoplasms; Radiography; Temozolomide; Tumor Suppressor Proteins	2011
Temozolomide-induced shrinkage of a pituitary carcinoma causing Cushing's disease--report of a case and literature review. TheScientificWorldJournal, 2010, Nov-04, Volume: 10 Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Antineoplastic Agents, Alkylating; Dacarbazine; Humans; Male; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Temozolomide; Treatment Outcome	2010
Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature. Pituitary, 2012, Volume: 15, Issue:3 Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Drug Resistance, Neoplasm; Glioblastoma; Humans; Liver Neoplasms; Male; O(6)-Methylguanine-DNA Methyltransferase; Pituitary Neoplasms; Temozolomide	2012
Temozolomide in aggressive pituitary adenomas and carcinomas. Clinics (Sao Paulo, Brazil), 2012, Volume: 67 Suppl 1 Topics: Adenoma; Antineoplastic Agents, Alkylating; Carcinoma; Dacarbazine; Humans; Pituitary Neoplasms; Temozolomide	2012

Trials

1 trial(s) available for dacarbazine and Adenoma

Article	Year
O(6)-methylguanine DNA methyltransferase immunoexpression in nonfunctioning pituitary adenomas: are progressive tumors potential candidates for temozolomide treatment? Cancer, 2009, Mar-01, Volume: 115, Issue:5 Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Dacarbazine; Female; Humans; Immunohistochemistry; Male; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Pituitary Neoplasms; Reoperation; Temozolomide; Time Factors	2009

Article

Year

O(6)-methylguanine DNA methyltransferase immunoexpression in nonfunctioning pituitary adenomas: are progressive tumors potential candidates for temozolomide treatment?

Cancer, 2009, Mar-01, Volume: 115, Issue:5

Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Dacarbazine; Female; Humans; Immunohistochemistry; Male; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Pituitary Neoplasms; Reoperation; Temozolomide; Time Factors

2009

Other Studies

39 other study(ies) available for dacarbazine and Adenoma

Article	Year
Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016. European journal of endocrinology, 2018, Volume: 178, Issue:3 Topics: Adenoma; Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Carcinoma; Carmustine; Child; Child, Preschool; Cranial Irradiation; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Endocrinology; Europe; Female; Humans; Ki-67 Antigen; Male; Middle Aged; Neoplasm Invasiveness; Neurosurgical Procedures; Pituitary Neoplasms; Societies, Medical; Surveys and Questionnaires; Temozolomide; Thalidomide; Tumor Suppressor Proteins; Young Adult	2018
High response rates and prolonged survival in patients with corticotroph pituitary tumors and refractory Cushing disease from capecitabine and temozolomide (CAPTEM): a case series. Neurosurgery, 2014, Volume: 74, Issue:4 Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Dacarbazine; Deoxycytidine; Female; Fluorouracil; Humans; Immunohistochemistry; Male; Middle Aged; Pituitary ACTH Hypersecretion; Temozolomide	2014
Multiple cerebral hemorrhagic foci from metastases during temozolomide treatment in a patient with corticotroph pituitary carcinoma. The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:8 Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cerebral Hemorrhage; Dacarbazine; Humans; Male; Middle Aged; Temozolomide	2014
The expression profile of Dopamine D2 receptor, MGMT and VEGF in different histological subtypes of pituitary adenomas: a study of 197 cases and indications for the medical therapy. Journal of experimental & clinical cancer research : CR, 2014, Jul-16, Volume: 33 Topics: Adenoma; Antibodies, Monoclonal, Humanized; Bevacizumab; Blotting, Western; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Female; Humans; Immunohistochemistry; Male; Pituitary Neoplasms; Receptors, Dopamine D2; Temozolomide; Tumor Suppressor Proteins; Vascular Endothelial Growth Factor A	2014
Temozolomide increases the number of mismatch repair-deficient intestinal crypts and accelerates tumorigenesis in a mouse model of Lynch syndrome. Gastroenterology, 2014, Volume: 147, Issue:5 Topics: Adenocarcinoma; Adenoma; Animals; Cell Proliferation; Cell Transformation, Neoplastic; Colorectal Neoplasms, Hereditary Nonpolyposis; Dacarbazine; Disease Models, Animal; DNA Mismatch Repair; Female; Intestinal Mucosa; Intestines; Male; Mice, Knockout; MutS Homolog 2 Protein; Neoplastic Stem Cells; Risk Factors; Temozolomide; Time Factors	2014
Pituitary atypical adenoma or carcinoma sensitive to temozolomide combined with radiation therapy: a case report of early identification and management. Turkish neurosurgery, 2014, Volume: 24, Issue:6 Topics: Adenocarcinoma; Adenoma; Adult; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Humans; Pituitary Neoplasms; Temozolomide; Treatment Outcome	2014
Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center. Journal of neuro-oncology, 2015, Volume: 122, Issue:1 Topics: Adenoma; Adult; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Pituitary Neoplasms; Prognosis; Retrospective Studies; Somatostatin; Survival Rate; Temozolomide; Tertiary Care Centers	2015
Long-lasting complete remission after therapy with temozolomide in two patients with macrocorticotropinoma causing Cushing's disease. Clinical endocrinology, 2015, Volume: 83, Issue:1 Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adult; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Pituitary ACTH Hypersecretion; Remission Induction; Temozolomide; Treatment Outcome; Tumor Burden	2015
Temozolomide retreatment in a recurrent prolactin-secreting pituitary adenoma: Hormonal and radiographic response. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2016, Volume: 22, Issue:3 Topics: Adenoma; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Prolactinoma; Retreatment; Temozolomide; Treatment Outcome	2016
Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide. The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:4 Topics: Adenoma; Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Biomarkers, Pharmacological; Biomarkers, Tumor; Carcinoma; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pituitary Neoplasms; Prognosis; Temozolomide; Treatment Outcome; Tumor Suppressor Proteins; Young Adult	2015
Disulfiram sensitizes pituitary adenoma cells to temozolomide by regulating O6-methylguanine-DNA methyltransferase expression. Molecular medicine reports, 2015, Volume: 12, Issue:2 Topics: AC133 Antigen; Acetaldehyde Dehydrogenase Inhibitors; Adenoma; Animals; Antigens, CD; Antineoplastic Agents, Alkylating; Bortezomib; Cell Survival; Dacarbazine; Disulfiram; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nestin; Peptides; Pituitary Neoplasms; Primary Cell Culture; Proteasome Inhibitors; Proteolysis; Temozolomide; Tumor Cells, Cultured; Tumor Suppressor Proteins; Ubiquitination; Xenograft Model Antitumor Assays	2015
Authors' Reply to "Pituitary Atypical Adenoma or Carcinoma Sensitive to Temozolomide Combined with Radiation Therapy: A Case Report of Early Identification and Management". Turkish neurosurgery, 2015, Volume: 25, Issue:4 Topics: Adenoma; Dacarbazine; Humans; Male; Pituitary ACTH Hypersecretion; Pituitary Neoplasms	2015
Temozolomide for aggressive ACTH pituitary tumors: failure of a second course of treatment. Pituitary, 2016, Volume: 19, Issue:2 Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adult; Antineoplastic Agents, Alkylating; Chemotherapy, Adjuvant; Dacarbazine; Disease Progression; Humans; Hydrocortisone; Male; Middle Aged; Neoplasm Invasiveness; Retrospective Studies; Temozolomide; Treatment Failure	2016
Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas. Journal of neuro-oncology, 2016, Volume: 126, Issue:3 Topics: Adenocarcinoma; Adenoma; Adult; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pituitary Neoplasms; Prognosis; Survival Rate; Temozolomide	2016
HIF-1α Inhibition Sensitized Pituitary Adenoma Cells to Temozolomide by Regulating Presenilin 1 Expression and Autophagy. Technology in cancer research & treatment, 2016, Volume: 15, Issue:6 Topics: Adenoma; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Dacarbazine; Hypoxia-Inducible Factor 1, alpha Subunit; Lysosomes; Pituitary Neoplasms; Presenilin-1; Rats; Temozolomide	2016
Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma. Pituitary, 2016, Volume: 19, Issue:4 Topics: Adenoma; Adult; Aged; Antineoplastic Agents, Alkylating; Bone Neoplasms; Chemoradiotherapy; Dacarbazine; Female; Humans; Liver Neoplasms; Lymph Nodes; Male; Middle Aged; Neuroendocrine Tumors; Pituitary Neoplasms; Positron-Emission Tomography; Temozolomide	2016
Widely metastatic atypical pituitary adenoma with mTOR pathway STK11(F298L) mutation treated with everolimus therapy. CNS oncology, 2016, Volume: 5, Issue:4 Topics: Adenoma; Adrenocorticotropic Hormone; AMP-Activated Protein Kinase Kinases; Antineoplastic Agents; Brain; Brain Neoplasms; Capecitabine; Dacarbazine; Everolimus; Female; Humans; Ki-67 Antigen; Magnetic Resonance Imaging; Middle Aged; Mutation; Pituitary Neoplasms; Protein Serine-Threonine Kinases; Temozolomide	2016
Aggressive Pituitary Adenomas: The Dark Side of the Moon. World neurosurgery, 2017, Volume: 97 Topics: Adenoma; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Pituitary Neoplasms; Postoperative Complications; Radiotherapy; Retrospective Studies; Temozolomide; Treatment Outcome; Tumor Suppressor Protein p53	2017
Long-term complete remission of Crooke's corticotropinoma after temozolomide treatment. Endokrynologia Polska, 2016, Volume: 67, Issue:5 Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Dacarbazine; Humans; Male; Middle Aged; Pituitary ACTH Hypersecretion; Temozolomide; Treatment Outcome	2016
Refractory pituitary adenoma: a novel classification for pituitary tumors. Oncotarget, 2016, Dec-13, Volume: 7, Issue:50 Topics: Adenoma; Adult; Aged; Antineoplastic Agents, Alkylating; Biopsy; Cell Proliferation; Dacarbazine; Disease Progression; Drug Resistance, Neoplasm; Fatal Outcome; Female; Humans; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Pituitary Neoplasms; Salvage Therapy; Temozolomide; Terminology as Topic; Time Factors; Treatment Outcome; Tumor Burden	2016
Use of temozolomide in aggressive pituitary tumors: case report. Neurosurgery, 2009, Volume: 64, Issue:4 Topics: Adenoma; Adult; Antineoplastic Agents, Alkylating; Cushing Syndrome; Dacarbazine; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Temozolomide	2009
Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor. Pituitary, 2011, Volume: 14, Issue:4 Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Dacarbazine; Deoxycytidine; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Invasiveness; Radiography; Temozolomide; Treatment Outcome	2011
MGMT immunoexpression in silent subtype 3 pituitary adenomas: possible therapeutic implications. Endocrine pathology, 2010, Volume: 21, Issue:3 Topics: Adenoma; Adolescent; Adult; Antineoplastic Agents; Biomarkers, Tumor; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Female; Humans; Immunohistochemistry; Male; Middle Aged; Pituitary Neoplasms; Promoter Regions, Genetic; Temozolomide; Tumor Suppressor Proteins; Young Adult	2010
Comment on "Non-surgical treatment of hormone-secreting pituitary tumors". Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2010, Volume: 17, Issue:9 Topics: Adenoma; Clinical Trials as Topic; Dacarbazine; Humans; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Somatostatin; Temozolomide; Treatment Outcome	2010
Parathyroid adenoma and chondrosarcoma after treatment of pediatric Hodgkin disease. Journal of pediatric hematology/oncology, 2010, Volume: 32, Issue:7 Topics: Adenoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Chondrosarcoma; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Hyperparathyroidism, Primary; Male; Mechlorethamine; Neoplasms, Second Primary; Parathyroid Neoplasms; Prednisone; Procarbazine; Vinblastine; Vincristine	2010
Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases. European journal of endocrinology, 2010, Volume: 163, Issue:6 Topics: Adenoma; Antineoplastic Agents, Alkylating; Carcinoma; Dacarbazine; Female; Humans; Male; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Pituitary Neoplasms; Prospective Studies; Salvage Therapy; Temozolomide	2010
Low immunohistochemical expression of MGMT in ACTH secreting pituitary tumors of patients with Nelson syndrome. Endocrine pathology, 2010, Volume: 21, Issue:4 Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Female; Humans; Immunohistochemistry; Male; Middle Aged; Nelson Syndrome; Temozolomide; Tumor Suppressor Proteins	2010
MGMT promoter methylation and immunoexpression in aggressive pituitary adenomas and carcinomas. Journal of neuro-oncology, 2011, Volume: 104, Issue:3 Topics: Adenoma; Adolescent; Adult; Antineoplastic Agents, Alkylating; Carcinoma; Dacarbazine; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Pituitary Neoplasms; Promoter Regions, Genetic; Statistics as Topic; Temozolomide; Young Adult	2011
Treatment of pituitary neoplasms with temozolomide: A review. Cancer, 2011, Sep-01, Volume: 117, Issue:17 Topics: Adenoma; Antineoplastic Agents, Alkylating; Carcinoma; Dacarbazine; Humans; Pituitary Neoplasms	2011
Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status. European journal of clinical investigation, 2011, Volume: 41, Issue:10 Topics: Adenoma; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Carcinosarcoma; Dacarbazine; Humans; O(6)-Methylguanine-DNA Methyltransferase; Pituitary Neoplasms; Temozolomide	2011
Temozolomide and pituitary adenoma. Journal of neurosurgery, 2011, Volume: 114, Issue:6 Topics: Adenoma; Antineoplastic Agents, Alkylating; Dacarbazine; Enzyme-Linked Immunosorbent Assay; Humans; Pituitary Neoplasms; Prolactin; Temozolomide	2011
Effect of temozolomide on cell viability in gonadotroph adenoma cell lines. Oncology reports, 2011, Volume: 26, Issue:3 Topics: Adenoma; Animals; Antineoplastic Agents, Alkylating; Apoptosis; Caspases; Cell Cycle; Cell Line, Tumor; Cell Survival; Dacarbazine; Enzyme Activation; Follicle Stimulating Hormone; Gonadotrophs; Luteinizing Hormone; Mice; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Temozolomide	2011
MGMT immunoexpression in growth hormone-secreting pituitary adenomas and its correlation with Ki-67 labeling index and cytokeratin distribution pattern. Endocrine, 2011, Volume: 40, Issue:2 Topics: Adenoma; Adult; Aged; Antineoplastic Agents, Alkylating; Cell Nucleus; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Female; Human Growth Hormone; Humans; Immunohistochemistry; Keratins; Ki-67 Antigen; Male; Middle Aged; Neoplasm Proteins; Pituitary Neoplasms; Protein Transport; Temozolomide; Tumor Suppressor Proteins	2011
Anti-VEGF therapy in pituitary carcinoma. Pituitary, 2012, Volume: 15, Issue:3 Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Dacarbazine; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Positron-Emission Tomography; Temozolomide; Vascular Endothelial Growth Factor A	2012
Non-uniform response to temozolomide therapy in a pituitary gonadotroph adenoma. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2012, Volume: 39, Issue:5 Topics: Adenoma; Antineoplastic Agents, Alkylating; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Gonadotrophs; Humans; Ki-67 Antigen; Luteinizing Hormone; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Temozolomide; Tumor Suppressor Proteins	2012
DNA mismatch repair protein (MSH6) correlated with the responses of atypical pituitary adenomas and pituitary carcinomas to temozolomide: the national cooperative study by the Japan Society for Hypothalamic and Pituitary Tumors. The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:3 Topics: Adenoma; Adult; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Data Collection; DNA Modification Methylases; DNA Repair Enzymes; DNA-Binding Proteins; Drug Resistance, Neoplasm; Female; Humans; Immunohistochemistry; Japan; Ki-67 Antigen; Male; Middle Aged; Pituitary Neoplasms; Retrospective Studies; Temozolomide; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Young Adult	2013
Inhibition of PI3K/AKT/mTOR pathway enhances temozolomide-induced cytotoxicity in pituitary adenoma cell lines in vitro and xenografted pituitary adenoma in female nude mice. Endocrinology, 2013, Volume: 154, Issue:3 Topics: Adenoma; Animals; Antineoplastic Agents, Alkylating; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Drug Synergism; Drug Therapy, Combination; Female; Human Growth Hormone; Humans; Mice; Mice, Nude; Phosphoinositide-3 Kinase Inhibitors; Pituitary Neoplasms; Prolactin; Proto-Oncogene Proteins c-akt; Quinoxalines; Signal Transduction; Sulfonamides; Temozolomide; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays	2013
[Hodgkin lymphoma of the nasopharynx associated with a pituitary adenoma]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2003, Volume: 44, Issue:12 Topics: Adenoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Hypophysectomy; Male; Middle Aged; Nasopharyngeal Neoplasms; Pituitary Neoplasms; Radiotherapy, Adjuvant; Sphenoid Sinus; Treatment Outcome; Vinblastine	2003
Increased susceptibility to chemotherapeutic alkylating agents of mice deficient in DNA repair methyltransferase. Carcinogenesis, 2000, Volume: 21, Issue:10 Topics: Adenoma; Animals; Antineoplastic Agents, Alkylating; Cell Death; Cyclophosphamide; Dacarbazine; Female; Lethal Dose 50; Lung Neoplasms; Lymphoma; Male; Mice; Mice, Knockout; Nimustine; O(6)-Methylguanine-DNA Methyltransferase; Testis; Thymus Neoplasms	2000